Auburn forms partnership to market oncology program
Auburn, Ala. -- Quantum Immunologics Inc., a private biotechnology company, is collaborating with Auburn University to bring the school's cancer immunotherapy program to the veterinary market.
Auburn, Ala.
-- Quantum Immunologics Inc., a private biotechnology company, is collaborating with Auburn University to bring the school's cancer immunotherapy program to the veterinary market.
Auburn and Quantum will form a new independently funded and joint-owned company, but Quantum will provide corporate and administrative management.
The partnership will rely on Auburn University College of Veterinary Medicine's knowledge of companion animal cancer therapy and Quantum's oncofetal antigen-based therapy.
The new company is expected to begin operations in mid-2010.
Clemson University breaks ground on South Carolina’s first veterinary school
Published: November 23rd 2024 | Updated: November 24th 2024The Harvey S. Peeler Jr College of Veterinary Medicine is one of several institutions that plans to welcome an inaugural class of veterinary students in 2026.
Read More
Presurgical evaluation and diagnostic imaging for canine mast cell tumors
November 7th 2024Ann Hohenhaus, DVM, DACVIM (Oncology, SAIM), delved into essential components of a diagnostic investigation of dogs with MCRs, including fine-needle aspiration and diagnostic imaging methods during her session at the NY Vet Show in New York, New York
Read More
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
